Strength Training for Older Breast Cancer Survivors

Status Completed

Clinical Trial Summary

Women aged 50 and older are disproportionately affected by breast cancer, not only in terms of new diagnoses, but also in terms of survivorship. Approximately 85% of women who receive a first diagnosis of breast cancer are aged 50 and over, thus older women constitute the largest group of breast cancer survivors. Yet, few studies have focused on evaluating whether physical activity and exercise interventions affect long-term symptoms, physical fitness and function, and body composition of older breast cancer survivors. Due to the combined effects of breast cancer, related treatments and aging it is likely that exercise is even more beneficial for older breast cancer survivors than for younger survivors. Along with the cancer-related symptom of fatigue common to cancer survivors, older survivors face age-related declines in bone and muscle mass, muscle strength, bone health and physical function (gait and balance) that are likely exacerbated by reduced physical activity in survivorship and side effects of adjuvant cancer treatment. All women, regardless of age, are at risk for breast cancer recurrence. Recent epidemiologic evidence suggests a link between exercise and reduced risk of cancer recurrence in breast cancer survivors. Strength training is specifically suited to reverse or slow age-related declines in bone, muscle, strength and function and has shown promise to reduce cancer-related fatigue. However, no controlled trials of strength training in older breast cancer survivors have been conducted.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00591747
Study type	Interventional
Source	OHSU Knight Cancer Institute
Contact
Status	Completed
Phase	N/A
Start date	November 2005
Completion date	June 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03273426` - Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.	N/A
Recruiting	`NCT04583124` - Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)	N/A
Recruiting	`NCT04489173` - TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer	Phase 2
Recruiting	`NCT02913573` - Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction	Phase 2
Completed	`NCT03124095` - Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer	N/A
Terminated	`NCT00251095` - Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer	Phase 3
Completed	`NCT05576545` - Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment	N/A
Active, not recruiting	`NCT03625635` - Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment	N/A
Recruiting	`NCT04799535` - Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Withdrawn	`NCT03266562` - Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography	N/A
Completed	`NCT00530868` - Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer	Phase 2
Recruiting	`NCT06255808` - Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor
Completed	`NCT04640220` - Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors	N/A
Completed	`NCT02970682` - SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer	Phase 2
Completed	`NCT02316561` - Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer	N/A
Terminated	`NCT00638963` - Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)	Phase 2
Terminated	`NCT00249301` - A Study of MLN8054 in Patients With Advanced Solid Tumors	Phase 1
Not yet recruiting	`NCT06056414` - Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation	N/A
Recruiting	`NCT05427071` - Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy	N/A
Recruiting	`NCT03740893` - PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer	Phase 2